Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension

Ongun M. C., Tonyali N. V., KAPLAN O., DEĞER İ., ÇELEBİER M., BAŞCI AKDUMAN N. E., et al.
Placenta, vol.137, pp.88-95, 2023 (SCI-Expanded) identifier identifier

Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines

Şenol Y., KAPLAN O., VARAN C., Demirtürk N., Öncül S., Fidan B. B., et al.
Journal of Drug Delivery Science and Technology, vol.79, 2023 (SCI-Expanded) Sustainable Development identifier

Plasma irisin and metabolomic response differ between concentric and isometric exercise Effets différents de l'exercice concentrique et de l'exercice isométrique sur l'irisine plasmatique et la réponse métabolomique

KARA Ö. S., ERCAN A., ÇELEBİER M., KAPLAN O., ÖNCÜL S., KORKUSUZ F.
Science and Sports, vol.37, no.7, pp.610-617, 2022 (SCI-Expanded) identifier identifier

A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients

Solmaz İ., KAPLAN O., ÇELEBİER M., LAY İ., Anlar B.
Turkish Journal of Medical Sciences, vol.52, no.4, pp.1299-1310, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells

Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.
Current Pharmaceutical Analysis, vol.17, no.10, pp.1272-1281, 2021 (SCI-Expanded) Sustainable Development identifier identifier

Bioanalytical Method Validation of an RP-HPLC Method for Determina-tion of Rifampicin in Liver Perfusion Studies

İZAT N., KAPLAN O., ÇELEBİER M., ŞAHİN S.
CURRENT PHARMACEUTICAL ANALYSIS, vol.17, no.7, pp.919-925, 2021 (SCI-Expanded) identifier identifier

UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples

Tasci Y., Findik R. B., Pekcan M. K., KAPLAN O., ÇELEBİER M.
CURRENT PHARMACEUTICAL ANALYSIS, vol.17, no.4, pp.474-483, 2021 (SCI-Expanded) identifier identifier

Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis

DEMİR S., KAPLAN O., ÇELEBİER M., SAĞ E., BİLGİNER Y., LAY İ., et al.
Seminars in Arthritis and Rheumatism, vol.50, no.6, pp.1238-1244, 2020 (SCI-Expanded) Sustainable Development identifier identifier identifier

Polycystic ovary syndrome in adolescents: Q-TOF LC/MS analysis of human plasma metabolome

ÇELEBİER M., KAPLAN O., Özel Ş., Engin-Üstün Y.
Journal of Pharmaceutical and Biomedical Analysis, vol.191, 2020 (SCI-Expanded) identifier identifier identifier

Past, present and future of metabolomic studies Metabolomik çalışmaların dünü, bugünü ve yarını

KAPLAN O., ÇELEBİER M.
Turkiye Klinikleri Journal of Medical Sciences, vol.40, no.3, pp.366-374, 2020 (SCI-Expanded) Sustainable Development identifier

Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels

Cevher H. A., Schaller D., Gandini M. A., KAPLAN O., Gambeta E., Zhang F. X., et al.
BIOORGANIC CHEMISTRY, vol.91, 2019 (SCI-Expanded) identifier identifier identifier

Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.
European Journal of Pharmaceutical Sciences, vol.123, pp.377-386, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

Articles Published in Other Journals

Comparison of Different Sample Preparation Techniques for Untargeted Metabolomics Utilizing Q-TOF LC/MS and MetaboAnalyst 4.0

Kaplan O., Koçak E., Çelebier M.
Current Metabolomics and Systems Biology, vol.8, pp.53-60, 2021 (Peer-Reviewed Journal)

Evaluation of Recent Data Processing Strategies on Q-TOF LC/MS Based Untargeted Metabolomics

KAPLAN O., ÇELEBİER M.
MASS SPECTROMETRY LETTERS, vol.11, no.1, pp.1-5, 2020 (ESCI) identifier identifier

Liquid-liquid extraction and ultrafiltration based sample preparation technique for Q-TOF LC/MS analysis of non-polar metabolites in human plasma samples

KOÇAK E., KAPLAN O., ÇELEBİER M.
Journal of Research in Pharmacy, vol.24, no.1, pp.38-43, 2020 (ESCI) Creative Commons License identifier identifier

Comparison of cell lysis techniques via q-tof lc/ms

KAPLAN O., ÖNCÜL S., ERCAN A., ÇELEBİER M.
Mass Spectrometry Letters, vol.11, no.2, pp.36-40, 2020 (ESCI) Sustainable Development identifier identifier

Determination of the physicochemical properties of piroxicam

ÇELEBİER M., NENNİ M., KAPLAN O., AKGEYİK E., KAYNAK M. S., ŞAHİN S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, vol.0, no.0, 2019 (Scopus) Creative Commons License identifier

Refereed Congress / Symposium Publications in Proceedings

Validation of an HPLC method for the determination of talazoparib from nanoparticle formulations

Taş B., Akdağ Çaylı Y., Aytekin E., Pehlivan S., Öner L., Kaplan O.
3rd International Gazi Pharma Symposium Series (GPSS-2021), 8 - 10 September 2021, pp.1-2

AN INNOVATIVE SAMPLE PREPARATION TECHNIQUE TO EVALUATE THE DIFFERENCES IN METABOLOME LEVELS FOR SYNOVIA AND FAT TISSUES

KARAÇOBAN L., KAPLAN O., MENDERES Y., ÇELEBİER M., KORKUSUZ F.
European Orthopaedic Research Society 28th Annual Meeting Congress, İzmir, Turkey, 17 - 18 September 2020

Bioanalytical Validation of an HPLC Method for the Analysis of Rifampicin Accumulation in Rat Liver

İzat N., Kir F., Kaplan O., Çelebier M., Şahin S.
8. BBBB International Conference on Pharmaceutical Sciences (8.BBBB 2019), İzmir, Turkey, 14 - 16 October 2019, pp.332-333

Comparison of different sample preparation techniques on human plasma samples for Q-TOF LC/MS based metabolite profiling

ÇELEBİER M., KAPLAN O., KOÇAK E.
Euroanalysis 2019, İstanbul, Turkey, 1 - 05 July 2019

Comparison of Metabolite Extraction Techniques for LC/MS Based Metabolomics on Human Blood Plasma

KAPLAN O., KOÇAK E., ÇELEBİER M.
International Multisciplinary Symposium on Drug Research Development - DRD 2019, Malatya, Turkey, 1 - 03 July 2019

Is It Possible To Use Pooled Plasma Samples For Large-Scale Human Metabolomic Studies? A Comparison Of The Metabolite Profiles Of Pooled Plasma Samples With Random Individual Samples Using Q-TOF LC/MS

ÇELEBİER M., KAPLAN O., OZEL Ş., ÜSTÜN Y., KOÇAK E.
1st International Congress on Analytical and Bioanalytical Chemistry, Antalya, Turkey, 27 - 30 March 2019

A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.
EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 March 2019 Sustainable Development

The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.
12 th International symposium on pharmaceutical sciences, 26 June 2018 Sustainable Development

GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 May 2018